CD27 and neoplasm: Within the seven-gene panel, CD27 is an emerging target for cancer immunotherapy [15,16,17,18] involved in PD1 and CD70 blockades [19,20,21,22], CD8+ T cell expansion [23], and anti-viral/anti-tumor T cell immunity [24].